🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is an open label, non-randomized study designed to evaluate the d...
Status
Terminated
Location
Johns Hopkins University
Start Date
2019-11-15
Trial ID
NCT03619655
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
The objective of this study is to assess the overall response rate, evaluat...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-01-09
Trial ID
NCT05661955
Treatments Being Tested
This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-01-29
Trial ID
NCT07208149
Treatments Being Tested
The immune system may be involved in the recognition and destruction of tum...
Status
Recruiting
Location
University Hospital of Besançon
Start Date
2025-02-10
Trial ID
NCT06626269
Treatments Being Tested
This study aims to describe the different treatment time, treatment mode an...
Status
Unknown
Location
Henan cancer hospital
Start Date
2022-05-30
Trial ID
NCT05359120
The present study has 5 parts. In Parts A and A1, the dose of intravenous (...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-04
Trial ID
NCT01295827
Treatments Being Tested
This is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplat...
Status
Terminated
Location
Quest Clinical Research
Start Date
2019-04-22
Trial ID
NCT03838367
The purpose of this study is to find out whether selinexor is an effective ...
Status
Recruiting
Location
Children's Hospital of Los Angeles (Data Collection Only)
Start Date
2023-08-01
Trial ID
NCT05985161
Treatments Being Tested